Metabolic liver inflammation in obesity does not robustly decrease hepatic and circulating CETP

Lisanne L. Blauw*, Zhuang Li, Sander S. Rensen, Jan Willem M. Greve, Aswin Verhoeven, Rico J. Derks, Martin Giera, Yanan Wang, Patrick C. N. Rensen

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background and aims: We recently showed that plasma cholesteryl ester transfer protein (CETP) is mainly derived from VSIG4-positive Kupffer cells. Activation of these cells by the bacterial endotoxin lipopolysaccharide (LPS) strongly decreases CETP expression. As Kupffer cell activation plays a detrimental role in the progression of non-alcoholic fatty liver disease (NAFLD), we aimed to study if metabolic liver inflammation is also associated with a decrease in hepatic and circulating CETP. Methods: We collected plasma and liver biopsy samples at various stages of NAFLD from 93 obese individuals who underwent bariatric surgery. Liver lobular inflammation was histologically determined, and liver CETP expression, CETP positive cells, circulating CETP concentrations, and liver VSIG4 expression were quantified. Results: Mean (SD) plasma CETP concentration was 2.68 (0.89) mu g/mL. In the presence of liver inflammation, compared to the absence of pathology, the difference in hepatic CETP expression was -0.03 arbitrary units (95% CI -0.26, 0.20), the difference in number of hepatic CETP positive cells (range 11-140 per mm(2)) was -20.0 per mm(2) (95% CI -41.6, 1.9), and the difference in plasma CETP was -0.35 mu g/mL (95% CI -0.80, 0.10). Hepatic VSIG4 expression was not associated with liver inflammation (0.00; 95% CI -0.15, 0.15). Conclusions: We found no strong evidence for a strong negative association between metabolic liver inflammation and CETP-related outcomes in obese individuals, although we observed consistent trends. These data indicate that metabolic liver inflammation does not mimic the strong effects of LPS on the hepatic expression and production of CETP by Kupffer cells. (C) 2018 The Authors. Published by Elsevier B.V.
Original languageEnglish
Pages (from-to)149-155
Number of pages7
JournalAtherosclerosis
Volume275
DOIs
Publication statusPublished - 1 Aug 2018

Keywords

  • CETP
  • Liver inflammation
  • Lipid metabolism
  • Obesity
  • ESTER TRANSFER PROTEIN
  • EXPRESSION IN-VITRO
  • TRANSGENIC MICE
  • KUPFFER CELLS
  • NONALCOHOLIC STEATOHEPATITIS
  • EXPERIMENTAL ENDOTOXEMIA
  • CHOLESTEROL HOMEOSTASIS
  • MESSENGER-RNA
  • DISEASE
  • NASH

Cite this